Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
105 hedge funds and large institutions have $407M invested in Epizyme, Inc in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 19 reducing their positions, and 15 closing their positions.
184% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 19
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
1% more funds holding
Funds holding: 104 → 105 (+1)
0% more call options, than puts
Call options by funds: $216K | Put options by funds: $216K
35% less capital invested
Capital invested by funds: $628M → $407M (-$220M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$33.5M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$7.06M |
| 3 |
BlackRock
New York
|
+$6.34M |
| 4 |
Millennium Management
New York
|
+$5.25M |
| 5 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$3.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$18.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.09M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.08M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$3.09M |
| 5 |
UONDDL
University of Notre Dame du Lac
South Bend,
Indiana
|
-$2.89M |
EPZM Hedge Fund Activity: Q4 2018 in Review
105 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2018, worth a combined $407M — down 35% from $628M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new EPZM positions and 15 closed out — a net gain of 1 holder — while 54 added to existing stakes and 19 trimmed.
The largest buyer was Redmile Group, adding an estimated $33.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $18.9M sold.
- 105 institutional investors held Epizyme, Inc (EPZM) as of Q4 2018, up from 104 in Q3 2018.
- Funds reported $407M of Epizyme, Inc stock for Q4 2018, down 35% quarter-over-quarter.
- 16 funds opened new Epizyme, Inc positions in Q4 2018 and 15 closed out, a net change of +1 holder.
- The largest Epizyme, Inc buyer in Q4 2018 was Redmile Group, an estimated $33.5M added.
- The largest Epizyme, Inc seller in Q4 2018 was Deerfield Management, an estimated $18.9M sold.
Based on aggregated 13F filings for Q4 2018.